Episode 55: The fate of Bristol-Myers-Celgene, the tragedy of SIDS, and health tech's challenges

Why can't investors think for themselves? How do parents cope with inexplicable tragedy? And is tech prepared for the toughest parts of health care?

Om Podcasten

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.